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The classic activation of adaptive immunity takes place in secondary lymphoid organs (SLOs) where antigen presentation by DCs to naïve T cells results in activation and functional differentiation of these T cells. The C-Cchemokine receptor type 7 (CCR7) has been described to be crucially involved in several fundamental processes shaping the structural and functional organization of the adaptive immune system. 7 CCR7 is regarded as a key receptor in the coordinated migration of naïve T cells and maturated DCs to and their localization within SLOs. Subsequently, CCR7 deficiency results in impaired homing and positioning of T-cell and DC populations within SLOs, thereby leading to a severely delayed induction of adaptive immune responses and impairment of central and peripheral tolerance. 7 However, CCR7 is expressed not only on naïve T cells and matured DCs but also on antigen experienced memory T cells, 8, 9 allowing their migration into tissues expressing the CCR7 ligands CCL19 and 21.
In this regard, recent studies suggested that the enhanced endothelial expression of CCR7 ligands in chronically inflamed organs 10, 11 or within atherosclerotic lesions 12 causes sustained T-cell recruitment to sites of inflammation. 13, 14 Moreover, because CCR7 deficiency results in accumulation of T cells in inflamed tissues, 9, 15 T-cell egress from sites of inflammation into draining lymph nodes also depends on CCR7.
Given the importance of CCR7 for facilitating the transition from innate to adaptive immune activation and its general role in T-cell migration, we investigated the impact of a systemic CCR7 deficiency on atherogenesis.
Methods Animals
CCR7-deficient mice (C57BL/6) were crossed with LDL receptordeficient mice (C57BL/6, Jackson Laboratories, Bar Harbor, Me) to obtain double-knockout mice (ccr7 Ϫ/Ϫ /ldlr Ϫ/Ϫ ). Littermates heterozygous for CCR7 (ccr7 Ϯ /ldlr Ϫ/Ϫ ) or homozygous for the wildtype (WT) allele (ccr7 ϩ/ϩ /ldlr Ϫ/Ϫ ) served as controls. All mice were kept under specific pathogen free conditions. All experiments were approved by the government animal ethics committee and carried out 
Results

CCR7 Deficiency Reduces Atherosclerotic Plaque Development
To investigate the impact of CCR7 on atherogenesis, atherosclerosis-prone ldlr Ϫ/Ϫ mice were crossed with ccr7 Ϫ/Ϫ mice. Atherosclerotic plaque development was analyzed after feeding 10-week-old male mice a high-cholesterol diet for 12 weeks. Aortic lipid deposition as a measure for plaque extent was assessed by en face preparation and subsequent Oil Red O staining ( Figure 1A , left). The atherosclerotic plaque area was reduced by Ͼ50% after 12 weeks of feeding (8.41Ϯ3.29% in ldlr Ϫ/Ϫ mice versus 3.63Ϯ1.25% in ccr7 Ϫ/Ϫ / ldlr Ϫ/Ϫ mice; meanϮSD; PϽ0.05, Figure 1B , left). Additionally, total lesion size in aortic root sections was analyzed after Oil Red O staining ( Figure 1A, right) Figure 1B , right).
CCR7 Deficiency Has No Impact on Lipoprotein Fractions or Body Weight
To determine whether differences in lipid metabolism could account for the decrease in atherosclerotic plaque development in ccr7 Ϫ/Ϫ /ldlr Ϫ/Ϫ mice, serum lipids were determined in plasma samples after a 12-hour fasting period. Levels of total cholesterol and high-density lipoprotein (HDL), LDL, and very low-density lipoprotein cholesterol fractions did not differ between the experimental groups ( Table 1) . Body weights before and after feeding did not differ between genotypes (Table 2 ).
CCR7 Deficiency Reduces Macrophage Accumulation in Atherosclerotic Plaques
Because macrophage recruitment into the vessel wall and subsequent formation of foam cells are hallmarks of atherosclerotic plaque development, we elucidated the role of CCR7 deficiency on macrophage content of aortic plaques by immunohistochemistry using a monocyte/macrophage staining (MOMA-2; Figure 1C , left). Macrophages within aortic root plaques were significantly reduced in ccr7 Figure 1C , right).
CCR7 Deficiency Increases Infiltration of DCs and T Cells in Atherosclerotic Plaques
To identify DCs within atherosclerotic lesions, immunohistochemical analyses were performed. We observed a small but statistically significant increase in CD11c ϩ cells in the aortic roots of ccr7
Ϫ/Ϫ mice versus 9.3Ϯ1.01% in ldlr Ϫ/Ϫ mice; meanϮSEM; Pϭ0.038; Figure 1D Figure 1E , right). These cells were located mainly within the adventitia as previously described by others. 16 Given the fact that CCR7 is critically involved in homing of naïve T cells and antigen-presenting DCs to SLOs, we also analyzed the presence of DCs and T cells in SLOs of ccr7 Ϫ/Ϫ /ldlr Ϫ/Ϫ and ldlr Ϫ/Ϫ mice. As expected, we observed significantly fewer DCs and T cells in the SLOs of ccr7
Ϫ/Ϫ mice compared with ldlr Ϫ/Ϫ mice ( Figure 1F and 1G). It may be argued that the analysis of lymph nodes more adjacent to the aorta reflects the traveling of T cells and DCs from atherosclerotic lesions more accurately. However, atherosclerosis is a systemic disease and oxLDL is a systemically detectable molecule, [17] [18] [19] so uptake of oxLDL by antigen-presenting cells may not be locally restricted. In The body weights before and after feeding did not differ with regard to the genotypes (meanϮSD; nϭ7 per group).
addition, a high-cholesterol diet administered orally may result in oxLDL formation already during digestion, so mesenteric lymph nodes (MLNs) may actually be one of the first SLOs facilitating contact of oxLDL-pulsed DCs with naïve T cells. Finally, MLNs drain the dominant part of the gastrointestinal organ system and thus may reflect the behavior of DCs and T cells in a large area of arterial vasculature.
CCR7 Deficiency Alters T-Cell Response
To investigate T helper cell responses in ccr7
mice, T-cell cytokine analyses were performed. Although Th1 cells have been ascribed a proatherogenic role mainly because of the secretion of interferon-␥ (INF␥), 6, 20 Figure 2A ), suggesting a compromised Th1 cell response in ccr7
mice. Interleukin-4 levels did not differ significantly between the genotypes after a cholesterol-rich diet (median with 25th and 75th percentiles; Pϭ0.29; Figure 2B ).
OxLDL-Pulsed DCs Upregulate CCR7 and Migrate Toward CCL19 In Vitro
Because of the substantial impact of oxLDL as a key molecule for atherogenesis with antigenic features, we stimulated immature WT DCs with oxLDL and investigated DC maturation. We observed that oxLDL-or lipopolysaccharidetreated DCs exhibited the morphology of mature DCs, whereas native LDL (nLDL) -loaded DCs remained morphologically immature ( Figure 3A) . Using real-time polymerase chain reaction, we observed that oxLDL but not nLDL induced a significant increase in CCR7 and myosin heavy chain-II (MHC-II) mRNA expression on DCs when normalized to ␤-actin after 24 hours of stimulation (median with 25th and 75th percentiles; PϽ0.05; Figure 3B , left). Fluorescence activated cell sorting (FACS) analysis also demonstrated an increase in CCR7/MHC-II double-positive DCs on stimulation with oxLDL ( Figure 3B, right) . In accordance with the increased expression of CCR7, only oxLDL-pulsed DCs migrated toward the CCR7 ligand CCL19 (median with 25th and 75th percentiles; PϽ0.05; Figure IA in the onlineonly Data Supplement) in a CCR7-dependent manner (me- 
OxLDL-Pulsed DCs Induce a Specific T-Cell Priming In Vitro
Because MHC-II gene expression was upregulated on oxLDL-loaded DCs, we investigated whether these cells are able to induce the proliferation of naïve T cells. Indeed, the rate of T-cell proliferation was significantly enhanced after cocultivation with oxLDL (10 and 50 g/mL) -pulsed DCs compared with T cells cocultivated with unstimulated DCs (control) (meanϮSEM; PϽ0.05 versus control; Figure 3C ). Next, we determined whether contact with oxLDL-pulsed DCs may result in upregulation of the specific T-cell receptor (TCR) V␤6, which has previously been identified as a prominent TCR within atherosclerotic lesions. 23 We confirmed V␤6 expression by FACS analysis and observed an oxLDL-specific proliferation of the T-cell clone carrying V␤6 (meanϮSD; PϽ0.05 versus control; Figure 4A ). V␤6 expression was also investigated in cell homogenates from aorta and SLOs with FACS analysis. TCR V␤6 was found to be significantly decreased in ccr7 Figure 4B , right).
CCR7-Dependent Migration of T Cells Into the Atherosclerotic Vessel Wall
To determine the possible role of CCR7 in T-cell migration into atherosclerotic aortas, equal numbers of cell tracker orange-labeled WT and cell tracker green-labeled ccr7 Ϫ/Ϫ splenic T cells were adoptively transferred into ldlr Ϫ/Ϫ mice on a high-cholesterol diet ( Figure 5 ). After 48 hours, mice were harvested to determine T-cell distribution. As expected, we observed a reduced capacity of ccr7 Ϫ/Ϫ T cells to migrate into the MLN compared with WT T cells. In blood samples, ccr7 Ϫ/Ϫ T cells were increased compared with WT T cells, whereas within the spleen, we found equal numbers of T cells independently of genotype. T cells from ccr7 Ϫ/Ϫ mice displayed a reduced migration into atherosclerotic aortas of recipient mice compared with the migration of WT T cells.
Injection of WT T Cells but Not CCR7
؊/؊
-Derived T Cells Primed on oxLDL-Pulsed DCs Reverses Impaired Atherosclerotic Plaque Development in ccr7
Ϫ/Ϫ /ldlr Ϫ/Ϫ
-Deficient Mice
We hypothesized that the impaired migratory capacity of CCR7-deficient DCs to SLOs results in a reduced oxLDLspecific T-cell priming, which is responsible for the decrease in atherosclerotic plaque development in this mouse model. Thus, we speculated that ex vivo T-cell priming with oxLDLpulsed DCs could restore plaque extent in ccr7
mice. Therefore, we cocultivated WT and ccr7 Ϫ/Ϫ -derived T cells with oxLDL-loaded DCs in vitro as described above and intravenously injected these T cells every 3 weeks into ccr7 Ϫ/Ϫ /ldlr Ϫ/Ϫ mice fed a cholesterol-rich diet for 3 months. Injection of ex vivo primed WT T cells cocultivated on oxLDL-pulsed DCs induced atherosclerosis in ccr7 Figure 6A and 6B). In contrast, injection of WT T cells cocultivated with nLDL-loaded DCs or injection of ccr7 Ϫ/Ϫ -derived T cells cocultivated with oxLDL-loaded DCs did not restore athero- Figure 6A and 6B). In line with the reduced extent of atherosclerosis, macrophage recruitment into aortic plaques was also enhanced in ccr7
Ϫ/Ϫ mice injected with oxLDL-but not with nLDLprimed T cells or oxLDL-primed CCR7
Ϫ/Ϫ -derived T cells (17.21Ϯ1.34%, oxLDL injected; 12.96Ϯ1.39%, nLDL injected; 8.31Ϯ2.02%, oxLDL-primed CCR7
Ϫ/Ϫ -derived T cells; meanϮSEM; PϽ0.05; Figure 6C and 6D).
Discussion
Activation of the innate immune system has long been recognized as fundamentally involved in atherosclerotic plaque development. More recently, evidence has been provided that the adaptive immunity is also causally involved in the initiation and progression of atherosclerosis. 2 However, both the interaction between innate and adaptive immunity and the true nature of adaptive immune responses in atherosclerosis are only partially characterized.
CCR7 is critical for directing the migration to and the positioning and interaction between naïve T cells and DCs within SLOs. 24 Thus, lack of CCR7 results in delayed activation of the adaptive immune system. To investigate the importance of CCR7 for atherogenesis, we crossbred ccr7 Ϫ/Ϫ mice on an atherosclerosis-prone ldlr Ϫ/Ϫ background. Here, we report that atherosclerotic plaque extent throughout the aorta was profoundly reduced in ccr7 Ϫ/Ϫ /ldlr Ϫ/Ϫ mice after 12 weeks of a high-cholesterol diet. Additionally, we could demonstrate a decreased proportion of macrophages in atherosclerotic plaques of ccr7 Ϫ/Ϫ /ldlr Ϫ/Ϫ mice. So far, studies investigating the impact of CCR7 on atherosclerosis are very limited and have reported a more atheroprotective role for this chemokine receptor. 25, 26 The discrepancies in our observations could be due to experimental differences. Whereas 1 group worked solely with blocking antibodies against CCR7 ligands CCL19/21 in a transplantation model, 25 the others exclusively investigated the migratory behavior of skin langerhans cells during the course of an atherogenic diet. 26 In contrast, our study is the first to use a genetically engineered CCR7 deficiency in an atherosclerosis-prone mouse model.
As already shown for other inflamed tissues, 27 immunohistochemical analysis revealed a modest but statistically significant local accumulation of CD11c ϩ cells in atherosclerotic plaques of ccr7 Ϫ/Ϫ /ldlr Ϫ/Ϫ mice, whereas the number of CD11c ϩ cells in SLOs was markedly reduced. 28 We attribute this finding to an impaired migration of CCR7-deficient CD11c ϩ cells to SLOs to present antigens and to evoke an immune response. However, a clear discrimination between DCs and macrophages is hardly feasible because both cell types express CD11c. 28, 29 In addition, we found an increase in CD3 ϩ and CD4 ϩ T cells, particularly in the adventitia of atherosclerotic plaques of ccr7 Ϫ/Ϫ /ldlr Ϫ/Ϫ mice. This observation is consistent with results from other groups demonstrating that ccr7 Ϫ/Ϫ T cells accumulate in inflamed tissue, whereas ccr7 ϩ/ϩ T cells emigrate from these tissues via the afferent lymph, 9, 15 which is said to have important implications for the generation and maintenance of the immune response.
Both T-cell activation and differentiation have been associated with atherogenesis. In particular, Th1 cells, characterized by secretion of INF␥, tumor necrosis factor-␣, and interleukin-2, 6, 20 have been implicated to be proatherogenic. 20 For example, Th1 cell cytokines trigger macrophages to release chemokine (C-C motif) ligand 2, 30 thereby mediating the recruitment of monocytes and activated T cells to atherosclerotic lesions and promoting further disease progression. In the present study, we found reduced systemic INF␥ levels, indicating a decrease in proinflammatory Th1 cell differentiation. In addition, we measured the expression of T-cell receptor V␤6, which has been demonstrated to be the predominant T-cell receptor in atherosclerotic lesions and linked to disease activity. 23 Accordingly, V␤6 expression was significantly reduced in the aorta of ccr7 Ϫ/Ϫ /ldlr Ϫ/Ϫ mice, pointing to an impaired activation of ccr7 Ϫ/Ϫ T cells within the aorta.
To approach the question of whether loss of CCR7 in T cells or in antigen-presenting cells is more important in this setting, we performed migration and ex vivo priming experiments with CCR7-competent and CCR7-deficient T cells. First, we investigated the migratory behavior of dye-labeled ccr7 Ϫ/Ϫ and ccr7 ϩ/ϩ T cells on injection into ldlr Ϫ/Ϫ mice while fed a cholesterol-rich diet. We observed a reduced migration of ccr7 Ϫ/Ϫ T cells into the inflamed aorta compared with ccr7 ϩ/ϩ T cells. These results indicate that both exit and initial entry of T cells into the vascular wall during atherogenesis require CCR7. Interestingly, the CCR7 ligands CCL19 and CCL21 are expressed not only within SLOs but also on endothelial cells in chronically inflamed organs. 10 -12 Furthermore, CCL19 and CCL21 expression is enhanced within atherosclerotic lesions of apolipoprotein E-deficient mice and in human atherosclerotic carotid plaques. 12 Although delayed entry of ccr7 Ϫ/Ϫ T cells to peripheral sites of antigen exposure may contribute to reduced atherosclerotic plaque development, we speculated that injection of ex vivo primed T cells may restore atherogenesis by compensating the loss of CCR7-coordinated contact between antigen-presenting DCs and naïve T cells in SLOs. Given the autoantigenic potential and critical importance of oxLDL in atherogenesis, we used this molecule for ex vivo maturation and activation of DCs. In line with other groups, we observed maturation and activation of DCs in response to contact with oxLDL and clonal expansion and proliferation of T cells cocultivated with oxLDL-pulsed DCs. 6, 23, 31, 32 We could also confirm an oxLDL-specific induction of TCR V␤6. However, although injection of oxLDL-primed WT T cells into ccr7 Ϫ/Ϫ / ldlr Ϫ/Ϫ mice induced the development of atherosclerotic plaques to an extent comparable to ldlr Ϫ/Ϫ mice, ccr7 Ϫ/Ϫ T cells did not restore atherogenesis. Thus, T-cell priming in SLOs is important but not sufficient to promote atherosclerotic plaque development.
Taken together, CCR7-dependent trafficking of T cells such as egress from inflamed tissue into the draining lymph node and (re)entry to sites of inflammation seems to be essential for the generation and maintenance of the immune response in atherosclerosis. In contrast to a traditional paradigm, local priming processes seem to be unable to generate or maintain an adaptive immune response to promote atherosclerotic plaque development. This finding broadens our understanding of the immunoinflammatory pathophysiology of atherosclerosis and may guide the understanding to novel therapeutic strategies.
